What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- DNA
Weibo Cai focuses on Nanotechnology, In vivo, Molecular imaging, Biodistribution and Cancer research.
The Nanotechnology study which covers Biocompatibility that intersects with Nanochemistry.
His In vivo research is multidisciplinary, incorporating perspectives in Positron emission tomography, Pharmacokinetics and Molecular biology.
His Molecular imaging research includes themes of Medical physics, Personalized medicine, Targeting ligands and Biochemistry.
His studies in Biodistribution integrate themes in fields like Internalization, Prostate cancer, Endocrinology and Renal physiology.
Weibo Cai has included themes like Cancer cell, Cancer, Metastasis and Pathology in his Cancer research study.
His most cited work include:
- In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice (1230 citations)
- Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy (866 citations)
- Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects (810 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include In vivo, Positron emission tomography, Biodistribution, Cancer research and Nanotechnology.
His research in In vivo intersects with topics in Molecular biology, Biophysics, In vitro and Drug delivery.
His Positron emission tomography research integrates issues from Molecular imaging, Magnetic resonance imaging and Pathology.
The various areas that Weibo Cai examines in his Molecular imaging study include Preclinical imaging, Pet imaging and Medical physics.
His Biodistribution research is multidisciplinary, relying on both Ex vivo, Pharmacokinetics, Pharmacology, Flow cytometry and Monoclonal antibody.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer cell, Cancer, Prostate cancer and Pancreatic cancer.
He most often published in these fields:
- In vivo (33.20%)
- Positron emission tomography (28.07%)
- Biodistribution (23.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (21.31%)
- Biodistribution (23.16%)
- In vivo (33.20%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Biodistribution, In vivo, Positron emission tomography and Monoclonal antibody.
The study incorporates disciplines such as Antibody, Flow cytometry, Prostate cancer and Immunotherapy in addition to Cancer research.
The concepts of his Biodistribution study are interwoven with issues in Ex vivo, Blood urea nitrogen, H&E stain, Molecular biology and Breast cancer.
The In vivo study combines topics in areas such as Oxidative stress, In vitro, Tumor microenvironment, Melanin and Acute kidney injury.
His studies examine the connections between Positron emission tomography and genetics, as well as such issues in Magnetic resonance imaging, with regards to Pathology.
His study on Drug delivery is covered under Nanotechnology.
Between 2018 and 2021, his most popular works were:
- Nanozyme: new horizons for responsive biomedical applications. (232 citations)
- ImmunoPET: Concept, Design, and Applications (49 citations)
- Ceria Nanoparticles Meet Hepatic Ischemia‐Reperfusion Injury: The Perfect Imperfection (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- DNA
Pharmacology, Positron emission tomography, In vivo, Biodistribution and Biophysics are his primary areas of study.
His Positron emission tomography study combines topics in areas such as Diabetes mellitus, Magnetic resonance imaging, Transplantation and Bioinformatics.
Weibo Cai usually deals with Magnetic resonance imaging and limits it to topics linked to Type 2 Diabetes Mellitus and Molecular imaging.
His research integrates issues of In vitro, Antibody and Cell biology in his study of In vivo.
His Biodistribution research incorporates themes from Preclinical imaging, Ex vivo, Nuclear medicine, CTLA-4 and Polyethylene glycol.
His Biophysics study integrates concerns from other disciplines, such as Tumor microenvironment, Nanoparticle, Iron oxide nanoparticles and Surface modification.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
